Fulvestrant (‘Faslodex’) in clinical practice: International experience from a Compassionate Use Programme
To access this article, please choose from the options below
PII: S0305-7372(05)00144-1
doi:10.1016/j.ctrv.2005.08.006
© 2005 Elsevier Ltd. All rights reserved.
